Commentary
The frequency and significance of isolated hepatitis B core antibody and the suggested management of patients
Khalid A. Al-Mekhaizeem, Michael Miriello and Averell H. Sherker
CMAJ October 16, 2001 165 (8) 1063-1064;
Khalid A. Al-Mekhaizeem
Mr. Miriello is with the Division of Medical Biochemistry, Sir Mortimer B. Davis–Jewish General Hospital, McGill University, Montreal, Que. At the time of writing, Dr. Al-Mekhaizeem and Dr. Sherker were with the Division of Gastroenterology, Sir Mortimer B. Davis–Jewish General Hospital, McGill University, Montreal, Que.
Michael Miriello
Mr. Miriello is with the Division of Medical Biochemistry, Sir Mortimer B. Davis–Jewish General Hospital, McGill University, Montreal, Que. At the time of writing, Dr. Al-Mekhaizeem and Dr. Sherker were with the Division of Gastroenterology, Sir Mortimer B. Davis–Jewish General Hospital, McGill University, Montreal, Que.
Averell H. Sherker
Mr. Miriello is with the Division of Medical Biochemistry, Sir Mortimer B. Davis–Jewish General Hospital, McGill University, Montreal, Que. At the time of writing, Dr. Al-Mekhaizeem and Dr. Sherker were with the Division of Gastroenterology, Sir Mortimer B. Davis–Jewish General Hospital, McGill University, Montreal, Que.
![Loading Loading](https://www.cmaj.ca/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
The frequency and significance of isolated hepatitis B core antibody and the suggested management of patients
Khalid A. Al-Mekhaizeem, Michael Miriello, Averell H. Sherker
CMAJ Oct 2001, 165 (8) 1063-1064;
Jump to section
Related Articles
- No related articles found.